E-ISSN 2231-3206 | ISSN 2320-4672
 

Original Research

Online Publishing Date:
06 / 04 / 2015

 


Lipid profile and its relationship with blood glucose levels in Metabolic Syndrome

Onkar Singh, Mrityunjay Gupta, Vijay Khajuria.


Abstract
Background: Metabolic syndrome (MetS) and its associated factors such as dyslipidemia and hyperglycemia are associated with increased risk of cardiovascular disease (CVD).

Aims and Objective: To assess lipid profile and its relation with blood glucose levels in patients with MetS.

Materials and Methods: This cross-sectional study included 72 male patients with MetS. Anthropometry, lipid profile, blood glucose, and presence of MetS (JIS criteria) were determined.

Results: High triglyceride (TG) level (>200 mg/dL, 44.4%) was the most common dyslipidemia followed by low levels of high-density lipoprotein cholesterol (<40 mg/dL, 19.4%). High total cholesterol levels (>240 mg/dL, 13.8%) and high low-density lipoprotein cholesterol levels (>160 mg/dL, 9.7%) were observed. On comparison, no significant differences in lipid levels of MetS patients with normal fasting glucose, impaired fasting glucose, and type 2 diabetes mellitus were observed.

Conclusions: Dyslipidemia was frequent in patients with MetS. High TG was the most common lipid abnormality, and a large number of patients had more than one abnormal lipid parameter. Based on their respective blood glucose levels, an identical pattern of dyslipidemia was observed in the study population.

Key words: Metabolic Syndrome; Dyslipidemia; Lipid Pattern; Type 2 Diabetes Mellitus


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Onkar Singh
Articles by Mrityunjay Gupta
Articles by Vijay Khajuria
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Onkar Singh, Mrityunjay Gupta, Vijay Khajuria. Lipid profile and its relationship with blood glucose levels in Metabolic Syndrome. Natl J Physiol Pharm Pharmacol. 2015; 5(2): 134-137. doi:10.5455/njppp.2015.5.051120141


Web Style

Onkar Singh, Mrityunjay Gupta, Vijay Khajuria. Lipid profile and its relationship with blood glucose levels in Metabolic Syndrome. https://www.njppp.com/?mno=167669 [Access: March 15, 2024]. doi:10.5455/njppp.2015.5.051120141


AMA (American Medical Association) Style

Onkar Singh, Mrityunjay Gupta, Vijay Khajuria. Lipid profile and its relationship with blood glucose levels in Metabolic Syndrome. Natl J Physiol Pharm Pharmacol. 2015; 5(2): 134-137. doi:10.5455/njppp.2015.5.051120141



Vancouver/ICMJE Style

Onkar Singh, Mrityunjay Gupta, Vijay Khajuria. Lipid profile and its relationship with blood glucose levels in Metabolic Syndrome. Natl J Physiol Pharm Pharmacol. (2015), [cited March 15, 2024]; 5(2): 134-137. doi:10.5455/njppp.2015.5.051120141



Harvard Style

Onkar Singh, Mrityunjay Gupta, Vijay Khajuria (2015) Lipid profile and its relationship with blood glucose levels in Metabolic Syndrome. Natl J Physiol Pharm Pharmacol, 5 (2), 134-137. doi:10.5455/njppp.2015.5.051120141



Turabian Style

Onkar Singh, Mrityunjay Gupta, Vijay Khajuria. 2015. Lipid profile and its relationship with blood glucose levels in Metabolic Syndrome. National Journal of Physiology, Pharmacy and Pharmacology, 5 (2), 134-137. doi:10.5455/njppp.2015.5.051120141



Chicago Style

Onkar Singh, Mrityunjay Gupta, Vijay Khajuria. "Lipid profile and its relationship with blood glucose levels in Metabolic Syndrome." National Journal of Physiology, Pharmacy and Pharmacology 5 (2015), 134-137. doi:10.5455/njppp.2015.5.051120141



MLA (The Modern Language Association) Style

Onkar Singh, Mrityunjay Gupta, Vijay Khajuria. "Lipid profile and its relationship with blood glucose levels in Metabolic Syndrome." National Journal of Physiology, Pharmacy and Pharmacology 5.2 (2015), 134-137. Print. doi:10.5455/njppp.2015.5.051120141



APA (American Psychological Association) Style

Onkar Singh, Mrityunjay Gupta, Vijay Khajuria (2015) Lipid profile and its relationship with blood glucose levels in Metabolic Syndrome. National Journal of Physiology, Pharmacy and Pharmacology, 5 (2), 134-137. doi:10.5455/njppp.2015.5.051120141